JP2012092341A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012092341A5 JP2012092341A5 JP2011255723A JP2011255723A JP2012092341A5 JP 2012092341 A5 JP2012092341 A5 JP 2012092341A5 JP 2011255723 A JP2011255723 A JP 2011255723A JP 2011255723 A JP2011255723 A JP 2011255723A JP 2012092341 A5 JP2012092341 A5 JP 2012092341A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- conjunctivitis
- compound
- acid
- length
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/790,182 | 2004-03-02 | ||
| US10/790,182 US7141552B2 (en) | 2000-01-10 | 2004-03-02 | Use of lipid conjugates in the treatment of diseases |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007501901A Division JP2008509229A (ja) | 2004-03-02 | 2005-03-02 | 疾病の治療における脂質複合体の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012092341A JP2012092341A (ja) | 2012-05-17 |
| JP2012092341A5 true JP2012092341A5 (enExample) | 2013-02-07 |
Family
ID=34919723
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007501901A Pending JP2008509229A (ja) | 2004-03-02 | 2005-03-02 | 疾病の治療における脂質複合体の使用 |
| JP2011255723A Pending JP2012092341A (ja) | 2004-03-02 | 2011-11-24 | 疾病の治療における脂質複合体の使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007501901A Pending JP2008509229A (ja) | 2004-03-02 | 2005-03-02 | 疾病の治療における脂質複合体の使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7141552B2 (enExample) |
| EP (2) | EP3354318A1 (enExample) |
| JP (2) | JP2008509229A (enExample) |
| AU (2) | AU2005218545B8 (enExample) |
| CA (1) | CA2558416C (enExample) |
| IL (1) | IL177847A0 (enExample) |
| WO (1) | WO2005084307A2 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608598B2 (en) * | 2000-01-10 | 2009-10-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of conjunctivitis |
| US8304395B2 (en) * | 2000-01-10 | 2012-11-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Lipid conjugates in the treatment of disease |
| US8501701B2 (en) * | 2000-01-10 | 2013-08-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Use of lipid conjugates in the treatment of disease |
| US7772196B2 (en) * | 2000-01-10 | 2010-08-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| US20060189568A1 (en) * | 2000-01-10 | 2006-08-24 | Saul Yedgar | Use of lipid conjugates in the treatment of infection |
| US20090325876A1 (en) * | 2004-09-29 | 2009-12-31 | Saul Yedgar | Use of lipid conjugates in the treatment of diseases associated with vasculature |
| US8076312B2 (en) * | 2000-01-10 | 2011-12-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Use of lipid conjugates in the treatment of disease |
| US8916539B2 (en) * | 2000-01-10 | 2014-12-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of disease |
| US7893226B2 (en) | 2004-09-29 | 2011-02-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Use of lipid conjugates in the treatment of diseases |
| WO2006054304A2 (en) * | 2004-11-17 | 2006-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of disease |
| US7141552B2 (en) * | 2000-01-10 | 2006-11-28 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| US7811999B2 (en) * | 2000-01-10 | 2010-10-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Use of lipid conjugates in the treatment of diseases |
| US9040078B2 (en) * | 2000-01-10 | 2015-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases of the nervous system |
| US8883761B2 (en) * | 2001-01-10 | 2014-11-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases associated with vasculature |
| CN1742623A (zh) * | 2005-07-13 | 2006-03-08 | 凌沛学 | 透明质酸磷脂复合物及其制备方法 |
| JP5339905B2 (ja) * | 2005-08-03 | 2013-11-13 | モリア バイオファーマスーティカルズ | 嚢胞性線維症における脂質複合体の使用及びその適用 |
| DE102005045152A1 (de) * | 2005-09-21 | 2007-03-22 | Stremmel, Wolfgang, Prof. Dr. | Verwendung von therapeutisch wirksamen Lipiden nebst Verfahren zur Herstellung von Organ-/Gewebe-spezifischen therapeutisch wirksamen Lipiden |
| US8859524B2 (en) | 2005-11-17 | 2014-10-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Lipid conjugates in the treatment of chronic rhinosinusitis |
| US8906882B2 (en) | 2005-11-17 | 2014-12-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Lipid conjugates in the treatment of allergic rhinitis |
| US20080183282A1 (en) * | 2006-03-09 | 2008-07-31 | Saul Yedgar | Use of lipid conjugates for the coating of stents and catheters |
| AU2006344178A1 (en) | 2006-06-09 | 2007-12-13 | Erasmus University Medical Center Rotterdam | Modulation of the immune system by inositol phospholipids |
| CA2705785A1 (en) * | 2006-11-14 | 2008-05-22 | Saul Yedgar | Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| EP2097086A4 (en) * | 2006-11-14 | 2012-01-11 | Yissum Res Dev Co | CONTACT LENS COMPOSITIONS |
| US20090281065A1 (en) * | 2008-05-09 | 2009-11-12 | Kemin Industries, Inc. | Use of Lysophospholipids to Treat Inflammation |
| AU2010247814B2 (en) * | 2009-05-11 | 2015-08-13 | Celsus Therapeutics Plc | Lipid-polymer conjugates, their preparation and uses thereof |
| AU2010257181A1 (en) * | 2009-06-02 | 2012-01-12 | Brian Charles Keller | Pure PEG-lipid conjugates |
| DK2706988T3 (da) | 2011-05-12 | 2020-01-20 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Liposomer omfattende polymer konjugerede lipider og relateret brug |
| EP2923710A1 (en) * | 2014-03-27 | 2015-09-30 | Universitätsklinikum Heidelberg | Bacterial phospholipase inhibitors as modulator of colonic bacterial flora |
| WO2019147990A1 (en) * | 2018-01-26 | 2019-08-01 | The Regents Of The University Of California | Methods and compositions concerning intestinal permeability |
| CN110183779B (zh) * | 2019-06-06 | 2021-08-24 | 宁波一舟塑胶有限公司 | 羧甲基纤维素铈作为阻燃剂在高分子聚合物材料中的应用 |
| CA3209491A1 (en) * | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL84252A (en) * | 1987-10-23 | 1994-02-27 | Yissum Res Dev Co | Phospholipase inhibiting compositions |
| DK0478715T3 (da) * | 1989-06-23 | 1996-08-05 | Liposome Co Inc | Målrettede liposomer og fremgangsmåder til liposom-protein-kobling |
| JPH0482893A (ja) * | 1990-07-23 | 1992-03-16 | Fuji Photo Film Co Ltd | ペプチド誘導リン脂質化合物およびそれを用いたポリペブチドリポソームの製造方法 |
| AU647814B2 (en) | 1990-07-24 | 1994-03-31 | Seikagaku Kogyo Kabushiki Kaisha | Phospholipid- or lipid-combining glycosaminoglycan, production thereof, and cancer metastasis inhibitor |
| JP2997018B2 (ja) * | 1990-07-24 | 2000-01-11 | 生化学工業株式会社 | 燐脂質又は脂質結合グリコサミノグリカン |
| US6022866A (en) | 1991-07-03 | 2000-02-08 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| AU2782792A (en) * | 1991-10-15 | 1993-05-21 | Warner-Lambert Company | Azabicyclo oxime and amine cholinergic agents and methods of treatment |
| JP3714683B2 (ja) | 1992-07-30 | 2005-11-09 | 生化学工業株式会社 | 抗リウマチ剤 |
| US6043231A (en) | 1993-03-02 | 2000-03-28 | The Research Foundation Of State Univ. Of New York | Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines |
| EP0952841A4 (en) * | 1994-08-05 | 2000-11-02 | Molecular Structural Biotechno | BIOMOLECULAR COMPLEXES FOR TARGETED TRANSPORTATION OF MEDICINAL PRODUCTS IN SPECIAL REGIONS |
| EP0871721A1 (en) | 1995-03-09 | 1998-10-21 | Novo Nordisk A/S | A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
| JPH11504319A (ja) * | 1995-04-20 | 1999-04-20 | ジー．ディー．サール アンド カンパニー | 酸化窒素シンターゼインヒビターとして有用な環状アミジノ薬剤 |
| US6033645A (en) * | 1996-06-19 | 2000-03-07 | Unger; Evan C. | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
| JP2001523216A (ja) | 1995-06-26 | 2001-11-20 | リサーチ．トライアングル．ファーマシューティカルズ | 新規のアジュバント組成物と、それからなるワクチン製剤 |
| US5785975A (en) * | 1995-06-26 | 1998-07-28 | Research Triangle Pharmaceuticals | Adjuvant compositions and vaccine formulations comprising same |
| JPH0930970A (ja) * | 1995-07-19 | 1997-02-04 | Taisho Pharmaceut Co Ltd | 抗菌剤 |
| JP3942205B2 (ja) | 1995-07-24 | 2007-07-11 | 生化学工業株式会社 | 神経疾患の治療剤 |
| US6071532A (en) | 1996-10-15 | 2000-06-06 | Emory University | Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
| WO1998051285A2 (en) * | 1997-05-15 | 1998-11-19 | Genzyme Corporation | Cationic amphiphile formulations |
| US6162787A (en) | 1999-04-02 | 2000-12-19 | Immudyne, Inc. | Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions |
| EP1046394A3 (en) * | 1999-04-19 | 2001-10-10 | ImaRx Pharmaceutical Corp. | Novel compositions useful for delivering compounds into a cell |
| US7101859B2 (en) * | 2000-01-10 | 2006-09-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| IL150628A0 (en) * | 2000-01-10 | 2003-02-12 | Yissum Res Dev Co | Use of lipid conjugates in the treatment of disease |
| US7141552B2 (en) * | 2000-01-10 | 2006-11-28 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| US7109167B2 (en) * | 2000-06-02 | 2006-09-19 | Bracco International B.V. | Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
-
2004
- 2004-03-02 US US10/790,182 patent/US7141552B2/en not_active Expired - Fee Related
-
2005
- 2005-03-02 EP EP17206166.5A patent/EP3354318A1/en not_active Ceased
- 2005-03-02 WO PCT/US2005/006591 patent/WO2005084307A2/en not_active Ceased
- 2005-03-02 AU AU2005218545A patent/AU2005218545B8/en not_active Ceased
- 2005-03-02 JP JP2007501901A patent/JP2008509229A/ja active Pending
- 2005-03-02 CA CA2558416A patent/CA2558416C/en not_active Expired - Lifetime
- 2005-03-02 EP EP05724186A patent/EP1758595A4/en not_active Withdrawn
-
2006
- 2006-08-31 IL IL177847A patent/IL177847A0/en unknown
-
2011
- 2011-03-15 AU AU2011201154A patent/AU2011201154B2/en not_active Ceased
- 2011-11-24 JP JP2011255723A patent/JP2012092341A/ja active Pending